Alpha Growth PLC Annual Financial Report (2121K)
31 December 2020 - 8:00PM
UK Regulatory
TIDMALGW
RNS Number : 2121K
Alpha Growth PLC
31 December 2020
Alpha Growth plc
("Alpha", or the "Company")
Publication of the 2020 Annual Report
Alpha Growth Plc (LSE: ALGW), the financial services specialist
in the growing Senior Life Settlement ("SLS") asset class will
publish on the Company's website its Annual Report for the year
ended 31 August 2020 (the '2020 Annual Report'). The 2020 Annual
Report is available at www.algwplc.com .
In compliance with Listing Rule 9.6.1 of the UK Financial
Conduct Authority ('FCA'), the 2020 Annual Report will in due
course be available for inspection at www.morningstar.co.uk/uk/NSM
.
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
For more information, please visit www.algwplc.com or contact
the following:
Alpha Growth Plc +44 (0) 20 3959 8600
Gobind Sahney, Executive Chairman info@algwplc.com
Pello Capital Limited +44 (0) 20 7710 9610
Mark Treharne mt@pellocapital.com
About Alpha Growth Plc
Specialist in Longevity Assets
Alpha Growth Plc is a financial advisory business providing
specialist consultancy, advisory, and supplementary services to
institutional and qualified investors globally in the multi-billion
dollar market of longevity assets. Building on its well-established
network, the Alpha Growth Group has a unique position in the
longevity asset services and investment business, as a listed
entity with global reach. The Group's strategy is to expand its
advisory and business services via acquisitions and joint ventures
in the UK and the US to attain commercial scale and provide
holistic solutions to alternative institutional investors who are
in need of specialised skills and unique access to deploy their
financial resource in longevity assets.
SLS Assets and Non-correlation
A SLS refers to the sale of an existing life insurance policy to
a third party for a cash payment. Such a payment will be in excess
of the policy's surrender value, but less than its face value.
After the sale, the purchaser becomes the policy's beneficiary and
assumes payment of its premiums. There are many reasons why policy
holders may choose to sell their life insurance policies and sales
are usually only undertaken when the insured person doesn't have a
known life-threatening illness. The SLS provides individuals with
policies the option to realise value from an asset under a
regulated transaction. As a longevity asset, the SLS is
non-correlated to the real estate, equity capital and commodity
markets. Its value is a function of time because as time passes the
value gets closer to the face value of the policy. Hence creating a
steady increase in the net asset value of the investment. This
makes it highly attractive to investors wishing to counteract
volatility within an investment portfolio and add yield.
Note: The Company only advises on and manages SLS Assets that
originate in the USA where the SLS market is highly regulated.
ENDS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACSEAEAFDAEEFEA
(END) Dow Jones Newswires
December 31, 2020 04:00 ET (09:00 GMT)
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Apr 2023 to Apr 2024